FDA inspection
Juno Therapeutics, Inc.: FDA inspection ending Sep 20, 2023
FDA inspection 1218201 · Voluntary Action Indicated (VAI) · Bothell, WA
Key facts
| Inspection ID | 1218201 |
|---|---|
| Firm | Juno Therapeutics, Inc. |
| FEI number | 3011834594 |
| Address | 1522 217th Pl Se |
| City | Bothell |
| State | WA |
| ZIP | 98021 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 20, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data